Document:

exh_101.htm

EXHIBIT 10.1

 

THIRD AMENDMENT TO CONSULTING AGREEMENT

THIS THIRD AMENDMENT (this “Amendment”) is made as of the 18th day of December, 2013 to that certain CONSULTING AGREEMENT, dated as of September 9, 2008, as amended (the “Consulting Agreement”), by JOS. A. BANK CLOTHIERS, INC. (“Client”) and ROBERT N. WILDRICK (“Consultant”).

FOR GOOD AND VALUABLE CONSIDERATION, the receipt and adequacy of which are hereby acknowledged, Client and Consultant, being the sole parties to the Consulting Agreement, hereby amend the Consulting Agreement by inserting therein immediately following Article XIII the following Article IX.

ARTICLE IX

INDEMNIFICATION

Section 9.1.                      Indemnification.

(a) In the event that Consultant was, is or becomes subject to, a party to or witness or other participant in, or is threatened to be made subject to, a party to or witness or other participant in, a Claim by reason of or arising, in whole or in part, out of an Indemnifiable Event, Client shall indemnify, defend and hold harmless Consultant, except to the extent such Indemnifiable Event is found by a court of competent jurisdiction to have resulted from Consultant’s willful misconduct, fraud or bad faith.   The obligations of Client pursuant to this Article IX shall extend upon the same terms and conditions to any business entity organized and controlled by Consultant (as referred to in Section 1.1) and the partners, directors, officers, employees, agents and controlling persons (if any), as the case may be, of Consultant and any such business entity.

(b) If so requested by Consultant, Client shall advance, or cause to be advanced (within two business days of such request), any and all Indemnifiable Expenses incurred by Consultant (an "Expense Advance"). Client shall, in accordance with such request (but without duplication), either (i) pay, or cause to be paid, such Indemnifiable Expenses on behalf of Consultant, or (ii) reimburse, or cause the reimbursement of, Consultant for such Indemnifiable Expenses. Consultant’s right to an Expense Advance is absolute and shall not be subject to any condition that the Board of Directors of Client shall not have determined that Consultant is not entitled to be indemnified under applicable law. However, the obligation of Client to make an Expense Advance pursuant to this Section 9.1(b) shall be subject to the condition that, if, when and to the extent that a final judicial determination is made (as to which all rights of appeal therefrom have been exhausted or lapsed) that Consultant is not entitled to be so indemnified under applicable law, Client shall be entitled to be reimbursed by Consultant (who hereby agrees to reimburse Client) for all such amounts theretofore paid (it being understood and agreed that the foregoing agreement by Consultant shall be deemed to satisfy any requirement that Consultant provide Client with an undertaking to repay any Expense Advance if it is ultimately determined that Consultant is not entitled to indemnification under applicable law). Client’s undertaking to repay such Expense Advances shall be unsecured and interest-free.

  

 

  

Section 9.2.                      Nonexclusivity. For the avoidance of doubt, the obligations of Client pursuant to this Article IX shall be separate and apart, and in addition to any obligations of Client to indemnify Consultant in any other capacity in which Consultant serves Client or any of its subsidiaries or affiliates, including, without limitation, as a director and Chairman of the Board, whether pursuant to the Restated Certificate of Incorporation of Client, the Amended and Restated Bylaws of Client, or that Indemnification Agreement dated as of September 1, 2009, between Client and Consultant, or otherwise, such other indemnification obligations to be subject to the terms and limitations applicable hereto.

Section 9.3.                      Insurance.  Client shall, to the extent available, obtain reasonable insurance providing Consultant with coverage for any liability asserted against, or incurred by or through, Consultant by reason of the fact that Consultant is or was or has agreed to serve as a consultant to Client, whether or not Client would have the power to indemnify Consultant against such liability under the provisions of this Agreement. In the event such coverage is available and Client fails to fulfill its obligation under the immediately preceding sentence, Consultant shall be entitled to obtain such coverage at Client’s expense and Client shall reimburse Consultants for all premiums and other reasonably related expenses incurred in procuring and maintaining such insurance. For purposes of this Section 9.3, reasonable insurance coverage shall be coverage which is consistent with Client’s directors’ and officers’ liability insurance in effect from time to time.

For the purposes of this Article IX, the following terms shall have the meanings set forth below:

 

Claim: means any threatened, asserted, pending or completed civil, criminal, administrative, investigative or other action, suit or proceeding of any kind whatsoever, including any arbitration or other alternative dispute resolution mechanism, or any appeal of any kind thereof, or any inquiry or investigation, whether instituted by Client, any governmental agency or any other party, that Consultant in good faith believes might lead to the institution of any such action, suit or proceeding, whether civil, criminal, administrative, investigative or other, including any arbitration or other alternative dispute resolution mechanism.

Indemnifiable Expenses: means all expenses and liabilities, including judgments, fines, penalties, interest, amounts paid in settlement with the approval of Client, and counsel fees and disbursements (including, without limitation, experts' fees, court costs, retainers, transcript fees, duplicating, printing and binding costs, as well as telecommunications, postage and courier charges) paid or incurred in connection with investigating, defending, being a witness in or participating in (including on appeal), or preparing to investigate, defend, be a witness in or participate in, any Claim by reason of the fact that Consultant is or was or has agreed to serve as a consultant to Client, any action or omission alleged to have been taken or omitted in any such capacity or Consultant’s performance of or failure to perform the Consulting Services, in each case whether occurring before, on or after the date of this Agreement (any such event, an “Indemnifiable Event”).

  

2

  

Except as specifically amended hereby, the Consulting Agreement shall remain in full force and effect according to its terms. To the extent of any conflict between the terms of this Amendment and the terms of the remainder of the Consulting Agreement, the terms of this Amendment shall control and prevail. Capitalized terms used but not defined herein shall have those respective meanings attributed to them in the Consulting Agreement. As used in the Consulting Agreement, the term “Company” shall refer to Client. This Amendment shall hereafter be deemed a part of the Consulting Agreement for all purposes.

           IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above written.

	
CLIENT:

JOS. A. BANK CLOTHIERS, INC.

	 	CONSULTANT:
	 	 	 	 	 
	By: 	 
 
/s/ SIDNEY H. RITMAN

	 	
/s/ ROBERT N. WILDRICK

	 	 
Sidney H. Ritman, Chairman

	 	 
ROBERT N. WILDRICK

	 	 
Compensation Committee

	 	 

 

 

3Exhibit 10.17

		 

August 6, 2013

 

Ms.
Karol Kain Gray

530
Copperline Drive

Chapel
Hill, North Carolina 27516

 

Re: Offer of Employment from Applied DNA Sciences, Inc.

 

 

Dear Karol

 

On behalf of Applied DNA Sciences, Inc. (“ADNAS”), I
am pleased to extend an offer of employment to you. This offer is contingent upon successful completion of a background check and
pre-employment drug screen. All such testing will be conducted in accordance with applicable federal, state, and local laws. As
discussed, your position is Chief Financial Officer (CFO). Your start date will be at your earliest convenience. This is a full
time position (100%), and you serve at the pleasure of the company president. The starting salary offered for this position is
three hundred thirty-six thousand ($336,000) per year, payable biweekly. In addition, after six (6) months employment, you will
be granted a five (5) year option to purchase up to two (2) million (2,000,000) shares of the Company’s Common Stock at the
fair market value on the date of the grant, based upon Board approval, as is customary in such matters. The option will vest in
four (4) equal annual increments beginning on the first anniversary of the grant date. This option grant is offered in compliance
with the Company’s existing Incentive Stock Plan (the “Plan”), as registered, and in compliance with existing
securities regulations. All provisions, restrictions and benefits of this Plan apply; a copy of the Plan is available upon request.

 

The Plan contains several terms and conditions related to your employment,
rights and privileges; and, as such, the Plan is part of this employment agreement.

 

You will receive twenty-six (26) days of vacation and twelve (12)
sick days. You are also eligible to participate in ADNAS 401(k) Plan on your first day of employment.

 

This offer is not to be considered a contract guaranteeing employment
for any specific duration. As an at-will employee, both you and the company have the right to terminate your employment at any
time with or without cause. We are excited about the potential that you bring to our company.

 

In connection with your employment with ADNAS,
Insperity handles the administrative responsibilities for human resources related issues such as payroll processing and benefits,
and it supports ADNAS in many personnel issues, while ADNAS handles the day-to-day activities related to its core business.

 

On your first day of employment, ADNAS will
provide additional information about the company’s objectives and policies, benefit programs, and general employment conditions.
To fulfill federal identification requirement, you should bring documentation to support your identity and eligibility to work
in the United States. 

 

50 Health Sciences Drive • Stony Brook,
NY 11790 • tel 631 240.8800 • fax 631 240.8900

    	 

    	 

    

 

 

For example, a valid U.S. passport or
Alien Registration Receipt Card are acceptable documents to establish both identity and employment eligibility. Additionally,
a current driver’s license or voter’s registration card in addition to a social security card or a certified
birth certificate copy will establish identity and eligibility to work. The types of acceptable documentation are listed on
the Form I-9 of the Immigration and Naturalization Service. Please contact me if you have any questions about which documents
are acceptable to verify your identity and eligibility to work in the United States. Applied DNA Sciences, Inc. participates
in the Department of Homeland Security U.S. Citizenship and Immigration Services E-Verify Program for
employment verification.

 

As we discussed, you will be working at our facilities in the Long
Island High Technology Incubator. You will report directly to Dr. James A. Hayward, the CEO and he will define your projects and
responsibilities.

 

PARKING

Parking is available on the LIHTI premises. You will need a LIHTI
parking hang tag and facilities card. There is one-time deposit for the parking hang tag of $25, refundable upon return of the
tag to LIHTI. This is a Stony Brook University policy.

 

Our offer of employment is contingent upon you
signing the Employment Agreement attached to this offer. Please feel free to contact our Human Resources department at 631-240-8808
if you have any questions. We look forward to your arrival at our company and we are confident that you will play a key role in
our company.

 

Sincerely yours,

 

 

 

Lawrence C. Kick, MA, SPHR

Director of Human Resources and Strategic Planning

Applied DNA Sciences, Inc.

 

    	 

    	 

    

 

Exhibit A

 

CONFIDENTIALITY
AGREEMENT

This Confidentiality,
NON-COMPETITION, NON-SOLICITATION AND DEVELOPMENTS] Agreement (this “Agreement”) is entered into as of
this ______th day August, 2013, by and between Applied DNA Sciences, Inc. a Delaware corporation with its principal
place of business at 50 Health Sciences Drive, Stony Brook, New York 11790 (“APDN”), and Karol Kain Gray, 530
Copperline Drive, Chapel Hill, North Carolina 27516 (the “Employee”).

 

For good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, APDN and the Employee hereby agree as follows:

 

1.                 
APDN possesses valuable business and technical information, know-how and trade secrets (whether written or oral) related to its
and its subsidiaries’ current, future and proposed products, including, but not limited to, research, developments, improvements,
methods, procedures, discoveries, patents, patent applications, inventions, processes, formulas, technology, designs, models, drawings,
product plans, products, services, customers, customer lists, strategies, studies, business plans, forecasts, markets, techniques,
engineering, testing systems, hardware configuration information, computer software and programs (including source code and related
documentation), test and/or experimental data and results, laboratory notebooks, marketing, finances or other business information
(herein collectively referred to as “Confidential Information”). Confidential Information shall include any
and all information relating to the Employee, and its subsidiaries, affiliates, clients, customers, investors, and joint venture
and strategic partners. 

2.                 
The Employee is an employee of APDN and as such APDN has and will disclose Confidential Information to the Employee. The Employee
shall not communicate APDN’s Confidential Information to any third party without the prior written consent of APDN, and the
Employee shall use its best efforts to prevent inadvertent disclosure of APDN’s Confidential Information to any third party.
The Employee hereby acknowledges that it is aware that United States securities laws prohibits any person who has received from
an issuer material, non-public information from purchasing or selling securities of such issuer or from communicating such information
to any other person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell such
securities.

3.                 
The obligation of Section 2 of this Agreement shall terminate with respect to any particular portion of APDN’s Confidential
Information when the Employee can document that the information is part of the public domain other than as a result of the Employee’s
or another person’s breach of duty to maintain confidentiality.

4.                 
In the event that the Employee is requested or required (by oral question or request for information or documents and legal proceedings,
interrogatories, subpoena, civil investigative demand or similar process) to disclose Confidential Information of APDN, or if the
Employee is advised by its legal counsel that it is legally required to disclose the Confidential Information, it is agreed that
the Employee (i) will provide APDN prompt notice of any request or requirement, (ii) will provide APDN full and complete cooperation
to seek an appropriate order or remedy, (iii) will cooperate with APDN in obtaining reliable assurances that confidential
treatment will be accorded to the disclosure of Confidential Information, and (iv) will, if disclosure of said Confidential Information
is required, disclose only that portion of the Confidential Information which is legally required to be disclosed.

    	 

    	 

    

 

5.                 
All materials including, without limitation, business or technical documents, drawings, models, apparatus, sketches, designs and
lists furnished to the Employee by APDN shall remain the property of APDN and shall be returned to APDN promptly at its request
with all copies, extracts or other reproductions (including computer tapes or discs) made thereof. It is further agreed that the
Employee will destroy any material it prepared based on its evaluation of the Confidential Information and shall confirm such destruction
in writing to APDN.

6.                 
The Employee will make full and prompt disclosure to APDN of all inventions, creations, improvements, discoveries, trade secrets,
secret processes, technology, know-how, methods, developments, software, and works of authorship or other creative works, whether
patentable or not, which are created, made, conceived or reduced to practice by him/her or under his/her direction or jointly with
others during his/her employment by APDN, whether or not during normal working hours or on the premises of APDN (herein collectively
referred to as “Developments”).

7.                 
The Employee agrees to assign and does hereby assign to APDN (or any person or entity designated by APDN) all his/her right, title
and interest in and to all Developments and all related patents, patent applications, copyrights and copyright applications. However,
this paragraph 7 shall not apply to Developments that do not relate to the present or planned business or research and development
of APDN and which are made and conceived by the Employee not during normal working hours, not on APDN’s premises and not
using APDNs tools, devices, equipment or Confidential Information. 

8.                 
The Employee agrees to cooperate fully with APDN and to take such further actions as may be necessary or desirable, both during
and after his/her employment with APDN, with respect to the procurement, maintenance and enforcement of copyrights, patents and
other intellectual property rights (both in the United States and foreign countries) relating to Developments. The Employee shall
sign all papers, including, without limitation, copyright applications, patent applications, declarations, oaths, formal assignments,
assignments of priority rights, and powers of attorney, which APDN may deem necessary or desirable in order to protect its rights
and interests in any Development. The Employee further agrees that if APDN is unable, after reasonable effort, to secure the signature
of the Employee on any such papers, any executive officer of APDN shall be entitled to execute any such papers as the agent and
the attorney-in-fact of the Employee, and the Employee hereby irrevocably designates and appoints each executive officer of APDN
as his/her agent and attorney-in-fact to execute any such papers on his/her behalf, and to take any and all actions as APDN may
deem necessary or desirable in order to protect its rights and interests in any Development, under the conditions described in
this sentence.

    	 

    	 

    

 

 

9.                 
Nothing herein shall be construed as giving the Employee any right in or to the Confidential Information, Developments, granting
the Employee any license under any intellectual property rights or representing any commitment by APDN to accept the Employee
as an investor or enter into any additional agreement, by implication or otherwise.The Employee agrees that unless
and until a definitive agreement with APDN has been executed and delivered, APDN shall not be under any legal
obligation to the Employee of any kind whatsoever with respect to a transaction by virtue of this or any written or oral
expression with respect to a transaction by any of the parties or their Representatives except for the matters specifically
agreed to in this Agreement. The parties further agree that each shall have no obligation to authorize or pursue with the
other or any other party any transaction and each understands that neither party has, as of the date hereof, authorized any
such transaction. The agreements set forth herein may be modified or waived only by a separate writing between the parties
expressly so modifying or waiving such agreements.

10.             
APDN has made no representation or warranty as to the accuracy or completeness of the Confidential Information and shall have no
liability to the Employee hereunder resulting from the use or contents of the Confidential Information or from any action taken
or any inaction occurring in reliance on the Confidential Information.

11.             
While employed by APDN the Employee shall devote all of his/her business time, attention, skill and effort to the faithful performance
of his/her duties for APDN. For a period of 1 year after the termination or cessation of the Employee’s employment for any
reason, the Employee will not, in the geographical areas that APDN or any of its subsidiaries does business or has done business
at the time of the Employee’s departure, directly or indirectly:

    (A)       Engage in any business or enterprise (whether as owner, partner, officer, director, employee, consultant, investor, lender or otherwise,
except as the holder of not more than 1% of the outstanding stock of a publicly-held company) that is competitive with APDN’s
business, including but not limited to any business or enterprise that develops, manufactures, markets, or sells any product or
service that competes with any product or service developed, manufactured, marketed or sold, or planned to be developed, manufactured,
marketed or sold, by APDN or any of its subsidiaries while the Employee was employed by APDN; or

    (B)        Either alone or in association with others: (i) solicit, recruit, induce, or attempt to solicit, recruit or induce, any employee
of APDN to leave the employ of APDN; or (ii) solicit, recruit, induce, or attempt to solicit, recruit or induce, any independent
contractor engaged by APDN to cease its engagement with APDN; provided, that clause (i) shall not apply to any individual whose
employment with APDN has been terminated for a period of six months or longer; or

    (C)        Either alone or in association with others, solicit, divert or take away, or attempt to solicit, divert or take away, the business
or patronage of any of the clients, customers or accounts, or prospective clients, customers or accounts, of APDN, which were contacted,
solicited or served by the Employee at any time during the term of the Employee’s employment with APDN.

12.             
The Employee acknowledges that this Agreement does not constitute a contract of employment; either express or implied, and does
not imply that APDN will continue the Employee’s employment for any period of time. This Agreement shall in no way alter
APDN’s policy of employment at will, under which both the Employee and APDN remain free to terminate the employment relationship,
with or without cause, at any time, with or without notice.

    	 

    	 

    

 

13.             
The Employee shall not issue a press release or make any other public statement that references this Agreement or uses APDN’s
name or trademarks for advertising or publicity purposes. 

14.             
The Employee acknowledges that money damages are an inadequate remedy for the irreparable harm that may be suffered by reason of
breach of this Agreement because of the difficulty of ascertaining the amount of damage that will be suffered by APDN. Therefore,
the Employee agrees that APDN may, in addition to any other available remedy, obtain specific performance of this Agreement and
injunctive relief against any breach or threatened breach hereof without the necessity of quantifying actual damages or posting
a bond and that the Employee shall not oppose the granting of such relief.

15.             
It is further understood and agreed that no failure or delay by APDN in exercising any right, power or privilege hereunder shall
operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or
the exercise of any right, power or privilege hereunder.

16.             
Under the terms of this Agreement, the rights and obligations accruing to APDN shall also accrue to APDN’s wholly-owned subsidiaries.
This Agreement shall not be assignable. This Agreement shall not be considered a consulting or employment contract.

17.             
This Agreement shall be construed in accordance with the laws of the State of New York. No conflicts-of-law which might refer such
construction and interpretation to the laws of another jurisdiction shall be considered. The New York State Supreme Court, County
of New York, or the United States District Court for the Southern District of New York shall have exclusive jurisdiction to adjudicate
any dispute arising in connection with this Agreement and each party hereby consents to such jurisdiction.

18.             
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, void
or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force
and effect and shall in no way be affected, impaired or invalidated.

19.             
This Agreement may be signed in more than one counterpart, each of which shall be deemed an original, and all of which together
shall constitute one and the same instrument.

	Applied DNA Sciences, Inc.	EMPLOYEE:
	 	 
	 	 
	By:	 
	 	 
	Name: Dr. James A. Hayward	Name: Karol Kain Grey
	Title: President  & CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}]]